August 14, 2020

Prostate Cancer Clinical Trials Lack Racial Diversity & It's Getting Worse

Investigators report that although 22% of prostate cancer diagnoses take place in non-Hispanic Black men, more than 96% of participants in prostate cancer clinical trials are non-Hispanic white men. That was the conclusion published in Cancer Epidemiology, Biomarkers, and Prevention. Furthermore, enrollment of African American men in prostate cancer studies since the year 1995 has...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.